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http://dx.doi.org/10.1016/j.jmii.2013Background/purpose: In industrialized countries, Clostridium difficile is the major cause of
nosocomial diarrhea. This study involved a broad overview of baseline epidemiology for
C. difficile in Taiwan.
Materials and methods: Point prevalence was estimated from a prospective survey conducted
in the respiratory care wards of six hospitals in central Taiwan. Polymerase chain reaction
(PCR) ribotyping and multiple-locus variable-number tandem-repeat analysis (MLVA) were per-
formed on all toxigenic C. difficile isolates, including asymptomatic and symptomatic strains.
Results: A total of 149 patients were screened for C. difficile; the point prevalence for C. diffi-
cile infection (CDI) and C. difficile colonization was 4% and 19%, respectively. CDI cases were
significantly related to end-stage renal disease, and C. difficile colonization cases were signif-
icantly associated with previous admission to an acute-care facility. No hypervirulent PCRl Region Laboratory, Centers for Disease Control, 5F, 20 Wen-Sin South 3rd Road, Taichung 40855,
tw (C.-S. Chiou).
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66 H.-L. Wei et al.ribotype 027 strain was found. MLVA detected two clusters of CDI-related and three clusters of
asymptomatic C. difficile strains circulating in wards.
Conclusion: Our results demonstrate a high prevalence of toxigenic C. difficile colonization in
hospitals. Infection control personnel should pay attention to the increasing numbers of CDI
cases, and molecular typing for C. difficile should be performed when necessary.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Clostridium difficile is the major cause of nosocomial
diarrhea and colitis in industrialized countries.1,2 The
spectrum of C. difficile infection (CDI) varies from asymp-
tomatic carriage or mild diarrhea to severe colitis, and it
may lead to megacolon, perforation, sepsis, and death.3
Since 2002, several outbreaks of severe colitis, caused by
the hypervirulent C. difficile strain NAP1/027, have been
recognized in health-care facilities in Canada, the United
States, and Europe4,5; the disease is highly associated with
advanced age, antacid use, antibiotic use, and increased
length of hospital stay.6
A few epidemiologic studies on C. difficile have been
conducted in Taiwan. In 2003, a 4-month prospective study
of intensive care unit (ICU) and infection wards found that
the average incidence of CDI was 1/1000 patient days.7
During 2007 and 2008, a 14-month retrospective survey
showed that the overall incidence in a southern medical
center was 4.3/10,000 patient days.8 Recently, a prospec-
tive study showed the average incidence in a northern
medical center to be 4.5/10,000 patient days, and indi-
cated a downward trend in CDI incidence.9 However, these
results are limited to single hospitals and may not reflect
the overall epidemiology in Taiwan. In addition, no suitable
molecular typing method was applied to detect the
endemic and/or epidemic strains.
To determine the burden of C. difficile on multiple long-
term respiratory care wards (RCWs), the baseline preva-
lence of both colonizing and infectious C. difficile strains
was estimated. Furthermore, polymerase chain reaction
(PCR) ribotyping, a classical method used to represent the
virulent strain of C. difficile,10 was performed on all C.
difficile isolates to detect the possible existence of the
hypervirulent C. difficile strain NAP1/027. Multiple-locus
variable-number tandem-repeat analysis (MLVA) typing,
one of the most discriminatory methods used for the mo-
lecular analysis of C. difficile strains,11 was used to detect
C. difficile clusters in wards. In conclusion, we present the
epidemiology of C. difficile in Taiwan, and provide evi-
dence for the presence of several asymptomatic and CDI-
related endemic strains in hospitals.Materials and methods
Patients, specimens, and facility
This research, including the collection of demographic and
clinical patient data and stool specimens, was approved bythe Institutional Review Boards at each investigative site.
Only those patients who were admitted to wards for more
than 48 hours were considered to be hospital-associated
patients, as recommended by the Ad Hoc Clostridium
difficile Surveillance Working Group.12 Information was
collected on patient age, sex, date of birth, date of
admission, ward of acquisition, clinical symptoms, under-
lying disease, and clinical treatment. We gathered this in-
formation through consultation with the physician or nurses
in charge.
RCWs of six hospitals in central Taiwan were involved in
this project. Stool specimens from each RCW were
collected over 3 days between April 21, 2009 and October
23, 2009. All stool specimens were transported using
anaerobic transport swabs and were delivered within 24
hours to the central-region laboratory at the Centers for
Disease Control in Taiwan for isolation of C. difficile. Fa-
cility data (such as location, type, and number of licensed
beds) were obtained from the website of the Bureau of
National Insurance, Taiwan Department of Health (http://
www.nhi.gov.tw/AmountInfoWeb/).
Definitions
A C. difficile strain was confirmed to be toxigenic by a
positive toxin test and/or toxigenic type determined by
PCR. Diarrhea was defined as 3 unformed stools per 24-
hour period.12 CDI was defined as the presence of diar-
rhea, in combination with a positive report for toxigenic
C. difficile and a negative culture for Salmonella species,
Shigella species, and Staphylococcus aureus. C. difficile
colonization was defined as a positive toxin test for
C. difficile, regardless of the presence of diarrhea. Previous
acute-care admission was defined as hospitalization in an
ICU for 2 weeks within 1 year. Antibiotic use was defined as
any antibiotic treatment for 1 week within the past 3
months.
DNA preparation
Genomic C. difficile DNA was purified using the QIAamp DNA
Mini kit (Qiagen, Hilden, Germany), according to the man-
ufacturer’s instructions. Genomic DNA isolated from
C. difficile was then used for PCR amplification of variable-
number tandem-repeat sequences and PCR ribotyping.
Isolation and determination of C. difficile
All stool specimens were cultured on cycloserine cefoxitin
fructose agar (Oxoid Ltd, Hampshire, UK) and were
Table 1 Point prevalence of Clostridium difficile coloni-












13 4 (31) 0 (0)
H2 Regional 43 11 (26) 5 (12) a
H3 Regional 8 2 (25) 0 (0)
H4 Area 34 8 (24) 0 (0)
H5 Regional 23 1 (4) 1 (4)
H6 Area 28 3 (11) 0 (0)
Total 149 29 (19) 6 (4)
a CDI clusters were detected in this ward.
CDI Z C. difficile infection; RCWs Z respiratory care wards.
Molecular typing and epidemiology of C. difficile 67incubated under anaerobic conditions for 48 hours. All
suspected C. difficile colonies were analyzed for a species-
specific internal fragment of the triose phosphate isom-
erase (tpi) housekeeping gene, and the toxigenic type was
characterized by PCR amplification of internal fragments of
the toxin A (tcdA) and toxin B (tcdB) genes, as previously
described.13 Briefly, each candidate colony was dissolved in
1 mL distilled water and boiled for 15 minutes to prepare
the DNA. Tpi-, tcdA-, and tcdB-specific primers13 were used
in separate PCR reactions. PCR was performed in 20 mL
volumes containing the following components: 50 ng
DNA, 10% glycerol, 0.5 mM of each primer, 200 mM dNTPs,
and 1 U of Taq DNA polymerase (BioVan, Taichung, Taiwan)
in a 1  amplification buffer solution [10 mM Tris-HCl (pH
8.3), 50 mM KCl, and 1.5 mM MgCl2]. PCR was performed
using a PTC-200 Thermal Cycler (MJ Research, Waltham,
MA, USA). The PCR cycle conditions were as follows: 95 C
for 3 minutes; followed by 30 cycles of 95C for 30 seconds,
55 C for 30 seconds, and 72 C for 30 seconds; and a final
extension at 72 C for 3 minutes. PCR products were
resolved by electrophoresis on a 1.5% agarose gel and
stained with ethidium bromide.
Enzyme immunoassay of C. difficile toxins A and B
All C. difficile isolates were analyzed for production of
toxins A and B using the ProSpect C. difficile Toxin A/B
Microplate Assay (Remel, Lenexa, KS, USA), according to
the manufacturer’s instructions. The kit’s sensitivity and
specificity are 90.3% and 96.2%, respectively, compared to
a tissue culture cytotoxicity assay.
MLVA typing
MLVA was conducted as described previously, using seven
loci (A6cd, B7cd, C6cd, E7cd, F3cd, G8cd, and H9cd) from
published MLVA schemes.14 The products were then
analyzed on an ABI3130 sequence detection system
(Applied Biosystems, Foster City, CA, USA), and the frag-
ment sizes or copy numbers were determined as
described.15 MLVA types with summed tandem-repeat dif-
ference of 10 were considered a cluster of C. difficile
isolates.
PCR ribotyping
Genomic DNA from all the C. difficile strains was amplified
with the primer set designed by Bidet et al,16 and
electrophoresis-based PCR ribotyping was performed using a
published method.15 PCR ribotypes 001, 012, 017, 027, and
106 were set up by comparing the curve files with the five
reference strains NCTC11204, NCTC13307, NCTC13366,
NCTC13287, and NCTC13404, respectively. All PCR ribotypes
were named with an “R” added prior to the serial number.
Point prevalence measurement and statistical
analysis
The point prevalence for CDI and C. difficile colonization
was determined as follows: Point prevalence rate Z CDI or
C. difficile colonization casesTotal RCW residents (149)
To evaluate the influence of different toxin determination
methods, characteristics of toxigenic isolates from
different groups (A,B, and C in Table S1) were analyzed by
Pearson’s Chi-square test and Fisher’s exact test. To assess
the factors associated with CDI and C. difficile coloniza-
tion, Pearson’s Chi-square test and Fisher’s exact test were
used for categorical data. Factors with p < 0.05 were
confirmed with multivariable logistic regression analysis, by
applying the backward stepwise variable selection proce-
dure. All tests were two tailed, and p < 0.05 was consid-
ered statistically significant. A p value between 0.1 and
0.05 represented a trend. Data were analyzed using the
SPSS software, version 14 (SPSS Inc., Chicago, IL, USA) or
Excel software (Microsoft, Redmond, WA, USA).Results
A total of 57 C. difficile strains were isolated from 149 RCW
residents; among them, 29 toxigenic strains were identified
by toxin test and/or toxigenic typing. The results of the
toxigenic isolates were as follows (Table S1): one isolate
was tested positive for the presence of the toxin but
negative for toxigenic type; three isolates were tested
negative for the presence of the toxin but positive for
toxigenic type; and 25 isolates were tested positive for the
presence of both toxin and toxigenic type.
Thepoint prevalence of CDI andC. difficile colonization in
central Taiwan is shown in Table 1. A total of 149 specimens
were collected, and the average point prevalence rates for
C. difficile colonization and CDI were 19% and 4%, respec-
tively (Table 1). The RCWs of six hospitals in central Taiwan
participated in this research, and the total number of beds
sampled represented 12.2% (149 in 1221) of the total beds of
the RCWs in central Taiwan. The point prevalence of
C. difficile colonization varied among hospitals and ranged
from 4% to 31%. The point prevalence of CDI also varied
amongdifferent hospitals; the rates inwards (H1,H3,H4,H5,
and H6) without CDI clusters ranged from 0% to 4%, whereas
that in the ward (H2) with two CDI clusters reached 12%.
Table 2 MLVA clusters and PCR ribotypes of Clostridium difficile isolates in RCWs of six hospitals from central Taiwan
Hospitals Strain name CDI PCR ribotype MLVA clustera MLVA profileb
A6cd-B7cd-C6cd-E7cd-F3cd-G8cd-H9cd
H1 1 N R18 30-19-17-5-5-9-8
2 N R10 E 32-15-31-5-9-5-7
3 N R10 E 32-14-36-5-9-5-7
4 N R59 27-17-41-8-5-10-8
H2 5 Y R10 A 36-16-31-5-9-5-7
6 Y R10 A 37-16-31-5-9-5-7
7 Y R10 A 37-16-31-5-9-5-7
8 N R10 A 36-16-30-5-9-5-7
9 Y R106 B 19-15-41-2-6-8-7
10 N R106 B 18-14-41-2-6-8-7
11 Y R106 24-8-23-2-6-11-7
12 N R45 C 32-16-19-4-6-8-11
13 N R45 C 33-16-19-4-6-8-11
14 N R45 C 25-16-19-4-6-7-11
15 N R66 23-17-31-6-8-15-31
H3 16 N R17 3-12-25-8-6-80-8
17 N R106 16-15-19-2-6-10-7
H4 18 N R106 D 19-16-45-2-6-8-7
19 N R106 D 19-15-44-2-6-8-7
20 N R106 D 19-15-45-2-6-8-7
21 N R106 19-15-27-2-6-8-7
22 N R7 16-9-20-4-6-9-7
23 N R10 24-16-33-4-9-7-7
24 ND R10 43-9-29-5-9-6-7
25 ND R10 41-16-32-5-9-5-7
H5 26 Y R66 18-9-30-6-5-10-8
H6 27 N ND 41-7-14-8-6-4-7
28 N R41 25-20-33-2-6-13-8
29 N R52 28-22-17-8-5-20-8
a Isolates with an STRD of 10 are defined as one MLVA cluster.
b Identified previously by van den Berg et al.14
CDI Z C. difficile infection; MLVA Z multiple-locus variable-number tandem-repeat analysis; N Z non-CDI case; ND Z no data;
PCR Z polymerase chain reaction RCW Z respiratory care ward; STRD Z summed tandem-repeat difference; Y Z CDI case.
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ribotypes were identified (Table 2). The hypervirulent 027
strain was not identified and the three most common PCR
ribotypes were R10, R106 (UK 106), and R45 (9, 8, and 3,
respectively). These PCR ribotypes were detected in mul-
tiple hospitals.
Five MLVA clusters were detected in 29 toxigenic C.
difficile isolates, and one (E), three (A, B, and C), and one
(D) clusters were identified in hospitals H1, H2, and H4,
respectively (Table 2). All MLVA clusters strains were
limited to individual hospitals. When these endemic strains
were compared with the corresponding clinical symptoms,
75% (3 of 4) and 50% (1 of 2) of isolates from clusters A and
B, respectively, were CDI cases. By contrast, all the isolates
in clusters C, D, and E were from asymptomatic C. difficile
carriers.
Of the 149 patients, 29 (19%) had C. difficile colonization
and six (4%) were CDI cases. The results for the multivari-
able analysis of the corresponding data are shown in Table
3. C. difficile colonization cases were significantly related
to prior admission to an acute-care facility (60.7% vs.
32.7%, p Z 0.009). CDI patients were more likely to haveend-stage renal disease (ESRD) (33% vs. 5%, pZ 0.022) than
non-CDI patients; there was also a trend toward exposure
to antacids (67% vs. 29%, p Z 0.072). No significant dif-
ferences were found between colonization and non-
colonization cases or between CDI and non-CDI patients
with respect to sex, age, or previous antibiotic treatment.Discussion
In the present study, the point prevalence and baseline
characteristics for either C. difficile colonization or infec-
tion of RCW patients were estimated. A high prevalence of
toxigenic C. difficile colonization in hospitalized patients
was discovered, and two CDI-related endemic strains and
three asymptomatic endemic strains were detected by
MLVA typing.
The CDI prevalence rate (4%) was similar to that ob-
tained in the study by Hung et al17 in southern Taiwan
(3.6%; 7/194) and was much lower than the prevalence
rates in countries that have experienced CDI outbreaks
(7e14.7%; Table 1).18e20 All the patients with CDI in this
Table 3 Characteristics for Clostridium difficile colonization and CDI cases of RCW patients in central Taiwana










Male 14 (50) 69 (61) d 2 (33) 81 (60) d
Age (y)
<65 5 (17.9) 11 (9.7) d 1 (16.7) 15 (11.1) d
65e85 13 (46.4) 66 (58.4) d 3 (50) 76 (56.3) d
>85 10 (35.7) 36 (31.9) d 2 (33.3) 44 (32.6) d
Past history
Acute care admission 17 (60.7) 37 (32.7) 0.009 2 (33.3) 52 (38.5)
Fecal incontinence 7 (25) 15 (13) d 1 (17) 18 (13) d
Antacid 13 (46) 30 (27) 4 (67) 39 (29) 0.072
Antibiotic used 19 (68) 61 (54) 3 (33) 78 (57)
Fluoroquinolone 0 (0) 6 (5.3) d 0 (0) 6 (4.4) d
Vancomycin 3 (10.7) 9 (8) d 1 (16.7) 11 (8.1) d
Clindamycin 0 (0) 1 (0.9) d 0 (0) 1 (0.7) d
Penicillin 13 (46.4) 30 (26.5) d 2 (33.3) 41 (30.3) d
Cephalosporin 2 (7.1) 22 (19.5) d 0 (0) 24 (17.8) d
Imipenem 2 (7) 10 (8.8) d 1 (16.7) 11 (8.1) d
Aminoglycoside 3 (10.7) 10 (8.8) d 1 (16.7) 12 (8.9) d
Any underlying disease 18 (64.3) 64 (56.6) d 5 (83.3) 77 (57) d
Diabetes 10 (36) 39 (35) d 3 (50) 46 (34) d
ESRD 3 (11) 6 (5) d 2 (33) 7 (5) 0.022
Malignancy 2 (7) 7 (6) d (0) (0) d
Stroke 9 (32) 35 (31) d 1 (17) 43 (32) d
a Stepwise backward logistic regression, final model retained variables with a p < 0.1.
Data are presented as n (%).
CDIZ C. difficile infection; CIZ confidence interval; ESRDZ end-stage renal disease; NG tubeZ naso gastric tube; ORZ odds ratio;
RCW Z respiratory care ward; eZ not significant.
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ribotyping of C. difficile isolates did not identify any
hypervirulent PCR ribotype 027 strain in the wards studied,
which was also true of two medical centers in northern and
southern Taiwan.17,21 Both the predominant PCR ribotypes
and their proportions in Taiwan differed significantly from
those found in England and North America. In England, the
three most common PCR ribotypes are 027, 106, and 001,
which accounted for 55%, 13%, and 9%, respectively, of all
CDI cases during the epidemic period of CDI between 2007
and 2009, whereas the rate decreased to 21%, 7%, and 7%,
respectively, in the endemic period.22 In Canada during the
epidemic period of CDI, the PCR ribotype 027 accounted for
80% isolates from all CDI cases.23 In Taiwan, the three most
common PCR ribotypes were reported to be R10 (31%), R106
(UK106; 27.5%), and R45 (10%); the proportions of dominant
strains were much less than those the other countries
experienced during the epidemic of CDI. The lack of highly
epidemic strains such as PCR ribotype 027 may explain the
low prevalence of CDI cases.
In this study, a strain that was positive for either toxi-
genic type or presence of toxin was defined as toxigenic;
therefore, our method was supposed to be more sensitive
than studies that have used only one method for toxin
detection. Riggs et al18 and the Canadian Nosocomial
Infection Surveillance Program (CNISP)19 used only the
enzyme immunoassay toxin test, whereas Hung et al’s17
study used only the real-time PCR method. We defined CDIas diarrhea that occurred three or more times in 1 day, with
a positive laboratory test for C. difficile. These criteria
were weaker than those of CNISP, which defined CDI as
diarrhea for more than 2 days with a positive laboratory
test.19 Therefore, the low CDI prevalence observed in our
study was not attributable to either the study method or
our definition of CDI.
Substantial colonization with C. difficile strains was
found in several hospitals (31% for H1, 26% for H2, 25% for
H3, and 24% for H4). These rates are similar to those in
hospitals with outbreaks that were reported in previous
studies (approximately 20%; Table 1),18,24 but only patients
in H2 progressed to diarrhea. Although colonization is
commonly believed to be a transmission source for
C. difficile and was used to predict the burden of CDI in
wards,25 our result indicates that the prevalence of CDI was
not confirmatively related to the number of toxigenic
C. difficile colonizing isolates.
MLVA typing differentiated CDI-related endemic strains
(A and B) from asymptomatic endemic strains (C, D, and E).
This observation may be a result of two factors. First, MLVA
cluster strains A and B may be more virulent than the other
MLVA cluster strains (C, D, and E; Table 2), and may be
responsible for the subsequent progression to diarrhea.
Second, the RCW residents may have had protective im-
munity against MLVA cluster strains C, D, and E; thus, these
strains could retain asymptomatic colonization, as was
observed by Samore et al.24 Therefore, while evaluating the
70 H.-L. Wei et al.burden of CDI, the MLVA types of toxigenic C. difficile
strains should be considered in addition to recording the
total number of colonizing isolates. This deduction has
some limitations: the asymptomatic carriers were not
traced for CDI development; and the results could partially
be a result of errors that occurred during the observation
period. These MLVA types of strains should be monitored to
confirm our conclusions.
By contrast, single PCR ribotypes (R10 and R106)
included the CDI-related MLVA cluster (A and B) and the
carriage-related MLVA cluster (E and D; Table 2); this shows
that PCR ribotyping was less sensitive for detecting invasive
strains than MLVA typing, although the former has been the
traditional method for detecting virulent strains.10
Patients with ESRD, or those who had been treated with
antacids, had higher rates of CDI in our study, and the data
were consistent with another study (Table 3).26 However,
the other conventional risk factors for CDI (advanced age
and antibiotic use)27 were not statistically significant (Table
3). The most probable reason for this result is the small
number of CDI cases (6 cases). Another possibility is that
the results indicate an endemic situation, because no large
outbreak was detected in any of the study wards; this sit-
uation was also observed by Hensgens et al.28
Previous admission to an acute-care facility was a risk
factor for C. difficile colonization, which is consistent with
other studies24,29 (Table 3). This may reflect increased
severity of the underlying disease or be explained by the
treatment in acute-care facilities. However, this factor is
not found to be significant in Riggs et al’s research.18 The
difference may be due to the fact that RCW patients are
usually transferred directly from an ICU; therefore, our CDI
cases might have had a shorter interval between prior ICU
exposure and the admission day than Riggs et al’s patients
and were more likely to have been influenced by treatment
in the ICU. In addition, different acute-care wards may use
different medical care strategies. Thus, the risk factors for
ICU patients in developing CDI should be studied further.
In other studies, antibiotic exposure was found to be a
major risk factor for C. difficile colonization.17,18 In our
study, previous antibiotic exposure was found in more
colonized patients than in noncolonized patients (68% vs.
54%), but was not statistically significant. Penicillin expo-
sure was significantly related to C. difficile colonization by
Chi-square test analysis (p Z 0.037), but not an indepen-
dent risk factor for C. difficile colonization when analyzed
by multivariable logistic regression. The results showed
that antibiotic exposure would increase the tendency of
developing C. difficile colonization. The low significance of
our statistics may be due to confounding factors such as
sample population, sample size, duration of antibiotic
treatment, and exposure to multiple antibiotics.29
Our survey has some limitations. First, different dura-
tions of exposure to antacids were defined as a single fac-
tor, which may produce less significant statistics with
respect to risk factors. Second, the prevalence study was
carried out between June and August in different hospitals,
and there was no control for seasonal influences, which
might have resulted in measurement bias.
In summary, the baseline characteristics and prevalence
for C. difficile in multiple RCWs in Taiwan were deter-
mined. The results of this study revealed a high prevalenceof toxigenic C. difficile colonization in hospitals in Taiwan.
Several asymptomatic and CDI-related endemic strains that
belonged to different MLVA types were circulating in the
wards of several hospitals. Infection control personnel
should be alert to the increasing number of CDI cases.
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